Editas (EDIT) CFO Amy Parison Sells 678 Shares

What Happened Amy Parison, Chief Financial Officer of Editas Medicine (EDIT), reported a sale of 678 shares on 2026-08-03 at $2.58 per share, for total proceeds of about $1,749. The transaction is a sale (code S) and was executed under an automatic instruction plan rather than as a discretionary trade.

Key Details

• Transaction date and price: 2026-08-03 — 678 shares @ $2.58 each (total ≈ $1,749).
• Reason/footnote: Sale effected pursuant to a durable automatic sales instruction plan adopted July 7, 2022; sale was to satisfy tax withholding obligations resulting from restricted stock units that vested on 2026-08-01. The filing notes the sale was not a discretionary trade by the reporting person.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing date: Form 4 filed 2026-08-05 covering the 2026-08-03 transaction (filed within the usual two-business-day window).

Context This was a routine tax-withholding sale tied to RSU vesting and executed under an automatic plan — such transactions are common and do not necessarily signal the insider’s view on company prospects. For retail investors, purchases generally carry more informational weight than automatic withholding sales.